Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.48 |
| ▸ | THRB | P10828 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2557411 | 1.00 | CYP3A4 (0.48) | CYP3A4THRBCYP2C9KDM4EMAPT | |
| Alteconazole SCHEMBL9748291 | 0.86 | CYP3A4 (0.49) | CYP3A4THRBCYP2C9KDM4EMAPT | |
| Alteconazole SCHEMBL30416434 | 0.86 | CYP3A4 (0.49) | CYP3A4THRBCYP2C9KDM4EMAPT | |
| Alteconazole SCHEMBL2110163 | 0.86 | CYP3A4 (0.49) | CYP3A4THRBCYP2C9KDM4EMAPT | |
| SCHEMBL4402362 | 0.84 | CYP3A4 (0.46) | CYP3A4THRBCYP2C9KDM4EHTT | |
| SCHEMBL13250541 | 0.81 | CYP3A4 (0.38) | CYP3A4THRBCYP2C9KDM4EHTT | |
| SCHEMBL3466478 | 0.81 | HTT (0.38) | CYP3A4THRBCYP2C9MAPTHTT | |
| SCHEMBL14693694 | 0.80 | THRB (0.39) | CYP3A4THRBCYP2C9MAPTHTT | |
| SCHEMBL9004933 | 0.80 | CYP3A4 (0.44) | CYP3A4THRBCYP2C9KDM4EHTT | |
| SCHEMBL10844736 | 0.80 | CYP3A4 (0.46) | CYP3A4THRBCYP2C9KDM4EHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100273651-A1 | Azolylmethyloxiranes, use Thereof and Agents Containing the Same | BASF SE (DE) | 2010-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100273651-A1 | Azolylmethyloxiranes, use Thereof and Agents Containing the Same | XDH, SQOR, NOX5 | CYP3A4 174/4885THRB 3767/4885CYP2C9 128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.